C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 495/04 (2006.01) A61K 31/4365 (2006.01) A61P 3/04 (2006.01)
Patent
CA 2652524
The present invention relates to a melanin concentrating hormone antagonist compound of formula (I): wherein R1, Ra, Rb, R2, L1, R3, R4 and R5 are as defined, or a pharmaceutically acceptable salt, enantiomer, diastereomer or mixture of diasteromers thereof useful in the treatment, obesity and related diseases.
La présente invention concerne un composé antagoniste de l'hormone de mélanoconcentration de formule : dans laquelle R1, Ra, Rb, R2, L1, R3, R4 et R5 sont comme défini, ou un sel, énantiomère, diastéréoisomère ou mélange de diastéréoisomères pharmaceutiquement acceptables de celui-ci utiles dans le traitement de l'obésité et de maladies associées.
Amegadzie Albert Kudzovi
Dao Yen
Gardinier Kevin Matthew
Garmene David Joseph
Green Steven James
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Novel mch receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel mch receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel mch receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1953982